Comparative Assessment of Adherence Measures and Resource Use in SSRI/SNRI-Treated Patients with Depression Using Second-Generation Antipsychotics or L-Methylfolate as Adjunctive Therapy

BACKGROUND: Antidepressant monotherapy is effective in achieving treatment remission in only approximately one third of patients with depression, and even switching to a second antidepressant brings the cumulative remission rate to only 50%-55%. This has led to an interest in augmentation therapy fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade, Rolin L., Kindermann, Sylvia L., Hou, Qingjiang, Thase, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438233/
https://www.ncbi.nlm.nih.gov/pubmed/24372461
http://dx.doi.org/10.18553/jmcp.2014.20.1.76

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438233/
https://www.ncbi.nlm.nih.gov/pubmed/24372461
http://dx.doi.org/10.18553/jmcp.2014.20.1.76

Ejemplares similares